安寐丹下调EphA4/EphrinA3信号通路蛋白表达改善老年睡眠剥夺模型认知功能的机制OA
Anmei Dan Improves Cognitive Function in Aged Sleep Deprivation Model by Downregulating Expression of Proteins in EphA4/EphrinA3 Signaling Pathway
目的:探讨安寐丹(AMD)是否通过抑制促红细胞生成素产生肝细胞受体 A4(EphA4)/Eph受体反应蛋白 A3(EphrinA3)信号通路及其下游Ras同源家族成员A(RhoA)/Rho相关卷曲螺旋形成蛋白激酶(ROCK)信号,改善老年睡眠剥夺模型小鼠的认知功能与昼夜节律紊乱,并分析其多靶点调节作用特点.方法:采用改良多平台水环境法建立老年C57小鼠睡眠剥夺模型,将小鼠随机分为空白组、模型组、钩藤碱(Rhy)拮抗剂组、拮抗剂加安寐丹组.安寐丹给药剂量为26.26 g·kg-1·d-1,Rhy为50 mg·kg-1·d-1,通过旷场实验评估自主活动活跃度,监测昼夜节律活动,苏木素-伊红(HE)与尼氏(Nissl)染色观察海马组织CA1/CA3区神经元形态,采用蛋白免疫印迹法(Western blot)、免疫荧光检测EphA4、EphrinA3、线粒体神经元核抗原(NEUN)、胶质纤维酸性蛋白(GFAP)、磷酸化(p)-EphA4、RhoA、Rho相关卷曲螺旋形成蛋白激酶1(ROCK1)、Rho相关卷曲螺旋形成蛋白激酶2(ROCK2)、脑源性神经营养因子(BDNF)、突触素(SYN)、突触后密度蛋白95(PSD95)、生长相关蛋白43(GAP43)等蛋白表达,实时荧光定量聚合酶链式反应(Real-time PCR)检测EphA4、EphrinA3 mRNA表达.结果:与空白组比较,模型组小鼠自主活动能力显著下降(P<0.01),昼夜节律紊乱(P<0.01),海马神经元排列紊乱、Nissl体减少,EphA4、EphrinA3、p-EphA4、RhoA、ROCK1、ROCK2、GFAP表达显著升高(P<0.01),NEUN、BDNF、SYN、PSD95、GAP43表达显著降低(P<0.01).与模型组比较,拮抗剂组与拮抗剂加安寐丹组上述指标均有显著改善(P<0.01),其中联合用药组在改善行为学、病理学及分子表达方面明显优于单纯拮抗剂组(P<0.05,P<0.01).结论:安寐丹可通过抑制EphA4/EphrinA3信号通路及其下游RhoA/ROCK信号通路、上调BDNF等突触相关蛋白表达,改善睡眠剥夺引起的认知与节律障碍,与EphA4拮抗剂联用具有协同增效作用,提示其具有多环节协同干预的机制特点.
Objective:To investigate whether Anmei Dan(AMD)improves cognitive function and alleviates circadian rhythm disorders in an aged mouse model of sleep deprivation by inhibiting the erythropoietin-producing hepatocellular receptor A4(EphA4)/Eph receptor-interacting protein A3(EphrinA3)signaling pathway and its downstream Ras homolog family member A(RhoA)/Rho-associated coiled-coil containing protein kinase(ROCK)signaling,and to analyze its multi-target regulatory characteristics.Methods:An aged C57 mouse model of sleep deprivation was established by the modified multiple platform water environment method.The mice were randomized into blank,model,rhynchophylline(Rhy,antagonist,50 mg·kg-1·d-1),and antagonist plus AMD(26.26 g·kg-1·d-1)groups.Spontaneous activity was assessed by the open field test,and circadian rhythm activity was monitored.Hematoxylin-eosin(HE)staining and Nissl staining were conducted to observe neuronal morphology in the hippocampal CA1/CA3 regions.Western blot and immunofluorescence assay were employed to determine the protein levels of EphA4,EphrinA3,Neuronal Nuclei Antigen(NEUN),glial fibrillary acidic protein(GFAP),phosphorylated(p)-EphA4,RhoA,Rho-associated coiled-coil containing protein kinase 1(ROCK1),Rho-associated coiled-coil containing protein kinase 2(ROCK2),brain-derived neurotrophic factor(BDNF),synaptophysin(SYN),postsynaptic density protein 95(PSD95),and growth-associated protein 43(GAP43).The mRNA levels of EphA4 and EphrinA3 were determined by real-time PCR.Results:Compared with the blank group,the model group showed decreased spontaneous activity(P<0.01),circadian rhythm disruption(P<0.01),hippocampal neuron disarrangement and reduced Nissl bodies,upregulated protein levels of EphA4,EphrinA3,NEUN,p-EphA4,RhoA,ROCK1,ROCK2,and GFAP(P<0.01),and downregulated protein levels of NEUN,BDNF,SYN,PSD95,and GAP43(P<0.01).Compared with the model group,both the antagonist group and the antagonist plus AMD group showed recovery in the above indicators(P<0.05,P<0.01),with the combination group outperforming the antagonist group in behavioral,pathological,and molecular expression aspects(P<0.05,P<0.01).Conclusion:AMD can alleviate cognitive and rhythm disorders caused by sleep deprivation by inhibiting the EphA4/EphrinA3 signaling pathway and its downstream RhoA/ROCK signaling,and upregulating the expression of synapse-related proteins such as BDNF.Its combination with an EphA4 antagonist exhibits a synergistic effect,which suggests that the mechanism involves multi-link synergistic intervention.
王子傲;王力春;王平;谢光璟
湖北中医药大学 基础医学院,武汉 430065||湖北中医药大学 老年脑健康中医药防护技术与新产品研发教育部工程研究中心,武汉 430065湖北中医药大学 基础医学院,武汉 430065||湖北中医药大学 老年脑健康中医药防护技术与新产品研发教育部工程研究中心,武汉 430065湖北中医药大学 老年脑健康中医药防护技术与新产品研发教育部工程研究中心,武汉 430065||湖北时珍实验室,武汉 430065湖北中医药大学 老年脑健康中医药防护技术与新产品研发教育部工程研究中心,武汉 430065||湖北时珍实验室,武汉 430065
医药卫生
安寐丹睡眠剥夺促红细胞生成素产生肝细胞受体A4/Eph受体反应蛋白A3(EphA4/EphrinA3)信号通路认知功能突触
Anmei Dan(AMD)sleep deprivationerythropoietin-producing hepatocellular receptor A4(EphA4)/Eph receptor-interacting protein A3(EphrinA3)signaling pathwaycognitive functionsynapse
《中国实验方剂学杂志》 2026 (17)
87-96,10
国家自然科学基金项目(82305354)
评论